Latest Breaking News On - Nancyu lin - Page 1 : comparemela.com

Olema Oncology Announces Phase 2 Monotherapy Clinical Results to be Presented at the 2023 ESMO Congress

Oral presentation by Dr. Nancy U. Lin from Dana-Farber Cancer Institute at 8:55 a.m. CEST/2:55 a.m. ET on October 22, 2023Olema will host an investor conference call at 8:00 a.m. ET on October 23,.

Dr Lin on the Selection of Systemic Therapy in HER2+ Breast Cancer With Brain Metastases

Systemic Therapy Shows Increasing Promise for CNS Metastases in Breast Cancer

Nancy U. Lin, MD, provides clinical insights on the treatment of patients with breast cancer brain metastases and discusses the advantages and disadvantages of systemic therapy vs radiation therapy for this population.

CDK4/6 Inhibitor Selection and Sequencing Continue to Evolve in HR+ Breast Cancer

Sarah Sammons, MD, discusses the evolving role of CDK4/6 inhibitors in hormone receptor–positive breast cancer, the future of antibody-drug conjugates in triple-negative breast cancer, and the importance of educating patients about their available treatment options so they can share in the decision-making process.

Clinical Challenges: Best Treatment Option for Breast Cancer Brain Metastases

Surgery and RT aren't going anywhere while systemic therapy gains ground